标准化高通量RNA提取:修改商业试剂盒,以提高纯度,产量和效率

IF 1.8 4区 医学 Q4 PHARMACOLOGY & PHARMACY
Ruwini D. Rajapaksha, Catherine Brooks, Adriana Rascon, Adam Fadem, Ivy Nguyen, Philip J. Kuehl, John T. Farmer
{"title":"标准化高通量RNA提取:修改商业试剂盒,以提高纯度,产量和效率","authors":"Ruwini D. Rajapaksha,&nbsp;Catherine Brooks,&nbsp;Adriana Rascon,&nbsp;Adam Fadem,&nbsp;Ivy Nguyen,&nbsp;Philip J. Kuehl,&nbsp;John T. Farmer","doi":"10.1016/j.vascn.2025.108379","DOIUrl":null,"url":null,"abstract":"<div><div>High-throughput extraction kits are widely use in clinical and preclinical settings to extract nucleic acids from biological samples due to their scalability, repeatability, and reduced labor. However, achieving high nucleic acid yield and purity while maintaining reliability and reproducibility remains challenging in molecular biology labs, partly due to lack of standardized guidelines for nucleic acid extractions and purification. Variations in extraction kits and extraction chemistries often lead to inconsistence results across experiments.</div><div>To address this variability, we modified manufacturers' extraction protocols by introducing additional chloroform and ethanol extraction steps. These modifications aimed to optimize RNA purity, yield, and extraction efficiency (EE) using Xeno Internal Positive Control (IPC) spiking as a benchmark. We evaluated the performance of three commercially available magnetic-bead-based RNA extraction kits across six naïve non-human primate (NHP) tissue types: brain, heart, kidney, liver, lung, and spleen, using the KingFisher™ Flex automated extraction platform.</div><div>The modified protocols demonstrated significant improvements in RNA purity, yield, and EE across the selected kits. These additional steps enhanced the suitability of extracted RNA for downstream applications, underscoring the importance of considering both kit performance and tissue characteristics in experimental design.</div><div>We further assessed the MagMAX™ <em>mir</em>Vana™ Total RNA Isolation Kit for its ability to remove interfering nucleic acids, such as plasmid DNA and single-stranded DNA (ssDNA), from adeno-associated viral (AAV) vector preparations. Specifically, we invesigated AAV serotype 8 (AAV8) due to its popularity in use for gene and cell therapies. The kit demonstrated high efficiency, removing ≥98 % of non-encapsidated genomes, plasmid DNA, and other impurities, yielding RNA suitable for downstream applications and removing contaminating DNA that would create a false-positive signal and result in over quantification.</div><div>These results emphasize the value of optimized, standardized protocols to improve reproducibility and reliability in RNA extraction workflows, with broad applications in molecular biology, gene therapy, and cell biology research.</div></div>","PeriodicalId":16767,"journal":{"name":"Journal of pharmacological and toxicological methods","volume":"135 ","pages":"Article 108379"},"PeriodicalIF":1.8000,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Standardizing high-throughput RNA extraction: Modifying commercial kits for improved purity, yield, and efficiency\",\"authors\":\"Ruwini D. Rajapaksha,&nbsp;Catherine Brooks,&nbsp;Adriana Rascon,&nbsp;Adam Fadem,&nbsp;Ivy Nguyen,&nbsp;Philip J. Kuehl,&nbsp;John T. Farmer\",\"doi\":\"10.1016/j.vascn.2025.108379\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>High-throughput extraction kits are widely use in clinical and preclinical settings to extract nucleic acids from biological samples due to their scalability, repeatability, and reduced labor. However, achieving high nucleic acid yield and purity while maintaining reliability and reproducibility remains challenging in molecular biology labs, partly due to lack of standardized guidelines for nucleic acid extractions and purification. Variations in extraction kits and extraction chemistries often lead to inconsistence results across experiments.</div><div>To address this variability, we modified manufacturers' extraction protocols by introducing additional chloroform and ethanol extraction steps. These modifications aimed to optimize RNA purity, yield, and extraction efficiency (EE) using Xeno Internal Positive Control (IPC) spiking as a benchmark. We evaluated the performance of three commercially available magnetic-bead-based RNA extraction kits across six naïve non-human primate (NHP) tissue types: brain, heart, kidney, liver, lung, and spleen, using the KingFisher™ Flex automated extraction platform.</div><div>The modified protocols demonstrated significant improvements in RNA purity, yield, and EE across the selected kits. These additional steps enhanced the suitability of extracted RNA for downstream applications, underscoring the importance of considering both kit performance and tissue characteristics in experimental design.</div><div>We further assessed the MagMAX™ <em>mir</em>Vana™ Total RNA Isolation Kit for its ability to remove interfering nucleic acids, such as plasmid DNA and single-stranded DNA (ssDNA), from adeno-associated viral (AAV) vector preparations. Specifically, we invesigated AAV serotype 8 (AAV8) due to its popularity in use for gene and cell therapies. The kit demonstrated high efficiency, removing ≥98 % of non-encapsidated genomes, plasmid DNA, and other impurities, yielding RNA suitable for downstream applications and removing contaminating DNA that would create a false-positive signal and result in over quantification.</div><div>These results emphasize the value of optimized, standardized protocols to improve reproducibility and reliability in RNA extraction workflows, with broad applications in molecular biology, gene therapy, and cell biology research.</div></div>\",\"PeriodicalId\":16767,\"journal\":{\"name\":\"Journal of pharmacological and toxicological methods\",\"volume\":\"135 \",\"pages\":\"Article 108379\"},\"PeriodicalIF\":1.8000,\"publicationDate\":\"2025-06-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of pharmacological and toxicological methods\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1056871925007993\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pharmacological and toxicological methods","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1056871925007993","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

高通量提取试剂盒因其可扩展性、可重复性和减少人工而广泛应用于临床和临床前环境,从生物样品中提取核酸。然而,在分子生物学实验室中,在保持可靠性和可重复性的同时实现高核酸产量和纯度仍然具有挑战性,部分原因是缺乏核酸提取和纯化的标准化指南。提取试剂盒和提取化学成分的差异常常导致实验结果不一致。为了解决这种可变性,我们修改了制造商的提取方案,引入了额外的氯仿和乙醇提取步骤。这些修饰旨在优化RNA纯度、产量和提取效率(EE),以Xeno内部阳性对照(IPC)为基准。我们使用KingFisher™Flex自动提取平台,评估了三种市购磁珠RNA提取试剂盒在六种naïve非人灵长类(NHP)组织类型(脑、心、肾、肝、肺和脾)中的性能。经过改进的方案在RNA纯度、产量和EE方面有了显著的提高。这些额外的步骤增强了提取的RNA对下游应用的适用性,强调了在实验设计中考虑试剂盒性能和组织特征的重要性。我们进一步评估了MagMAX™mirVana™总RNA分离试剂盒从腺相关病毒(AAV)载体制备中去除干扰核酸(如质粒DNA和单链DNA (ssDNA))的能力。具体来说,我们研究了AAV血清型8 (AAV8),因为它在基因和细胞治疗中很受欢迎。该试剂盒显示出高效率,去除≥98%的非封装基因组、质粒DNA和其他杂质,产生适合下游应用的RNA,去除可能产生假阳性信号和导致过度定量的污染DNA。这些结果强调了优化、标准化方案的价值,以提高RNA提取工作流程的可重复性和可靠性,在分子生物学、基因治疗和细胞生物学研究中具有广泛的应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Standardizing high-throughput RNA extraction: Modifying commercial kits for improved purity, yield, and efficiency
High-throughput extraction kits are widely use in clinical and preclinical settings to extract nucleic acids from biological samples due to their scalability, repeatability, and reduced labor. However, achieving high nucleic acid yield and purity while maintaining reliability and reproducibility remains challenging in molecular biology labs, partly due to lack of standardized guidelines for nucleic acid extractions and purification. Variations in extraction kits and extraction chemistries often lead to inconsistence results across experiments.
To address this variability, we modified manufacturers' extraction protocols by introducing additional chloroform and ethanol extraction steps. These modifications aimed to optimize RNA purity, yield, and extraction efficiency (EE) using Xeno Internal Positive Control (IPC) spiking as a benchmark. We evaluated the performance of three commercially available magnetic-bead-based RNA extraction kits across six naïve non-human primate (NHP) tissue types: brain, heart, kidney, liver, lung, and spleen, using the KingFisher™ Flex automated extraction platform.
The modified protocols demonstrated significant improvements in RNA purity, yield, and EE across the selected kits. These additional steps enhanced the suitability of extracted RNA for downstream applications, underscoring the importance of considering both kit performance and tissue characteristics in experimental design.
We further assessed the MagMAX™ mirVana™ Total RNA Isolation Kit for its ability to remove interfering nucleic acids, such as plasmid DNA and single-stranded DNA (ssDNA), from adeno-associated viral (AAV) vector preparations. Specifically, we invesigated AAV serotype 8 (AAV8) due to its popularity in use for gene and cell therapies. The kit demonstrated high efficiency, removing ≥98 % of non-encapsidated genomes, plasmid DNA, and other impurities, yielding RNA suitable for downstream applications and removing contaminating DNA that would create a false-positive signal and result in over quantification.
These results emphasize the value of optimized, standardized protocols to improve reproducibility and reliability in RNA extraction workflows, with broad applications in molecular biology, gene therapy, and cell biology research.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of pharmacological and toxicological methods
Journal of pharmacological and toxicological methods PHARMACOLOGY & PHARMACY-TOXICOLOGY
CiteScore
3.60
自引率
10.50%
发文量
56
审稿时长
26 days
期刊介绍: Journal of Pharmacological and Toxicological Methods publishes original articles on current methods of investigation used in pharmacology and toxicology. Pharmacology and toxicology are defined in the broadest sense, referring to actions of drugs and chemicals on all living systems. With its international editorial board and noted contributors, Journal of Pharmacological and Toxicological Methods is the leading journal devoted exclusively to experimental procedures used by pharmacologists and toxicologists.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信